Baseline dermoscopic patterns predict long-term changes in nevus diameter and in dermoscopic features.

Autor: Reiter O; Dermatology Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA.; School of Medicine, Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel., Mimouni T; School of Medicine, Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel., Scope A; School of Medicine, Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel.; The Kittner Skin Cancer Screening and Research Institute, Sheba Medical Center, Ramat Gan, Israel., Kurtansky NR; Dermatology Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Pastore L; Dermatology Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Halpern AC; Dermatology Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Marghoob AA; Dermatology Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA.

Publikováno v: Journal of the European Academy of Dermatology and Venereology : JEADV [J Eur Acad Dermatol Venereol] 2024 Dec 16. Date of Electronic Publication: 2024 Dec 16.

Insights into Porphyromonas somerae in Bladder Cancer Patients: Urinary Detection by ddPCR.

Autor: Russo F; Department of Molecular Medicine and Medical Biotechnologies, University of Naples Federico II, 80131 Naples, Italy.; CEINGE Biotecnologie Avanzate-Franco Salvatore S.C.A.R.L., 80131 Naples, Italy., Esposito S; Department of Molecular Medicine and Medical Biotechnologies, University of Naples Federico II, 80131 Naples, Italy.; CEINGE Biotecnologie Avanzate-Franco Salvatore S.C.A.R.L., 80131 Naples, Italy., Tripodi L; Department of Molecular Medicine and Medical Biotechnologies, University of Naples Federico II, 80131 Naples, Italy.; CEINGE Biotecnologie Avanzate-Franco Salvatore S.C.A.R.L., 80131 Naples, Italy., Pandolfo SD; CEINGE Biotecnologie Avanzate-Franco Salvatore S.C.A.R.L., 80131 Naples, Italy.; Department of Neurosciences, Reproductive Sciences and Odontostomatology, University of Naples Federico II, 80130 Naples, Italy.; Department of Urology, University of L'Aquila, 67010 L'Aquila, Italy., Aveta A; CEINGE Biotecnologie Avanzate-Franco Salvatore S.C.A.R.L., 80131 Naples, Italy.; Department of Urology, Ospedale del Mare, ASL NA1 Centro, 80147 Naples, Italy., Amato F; Department of Molecular Medicine and Medical Biotechnologies, University of Naples Federico II, 80131 Naples, Italy.; CEINGE Biotecnologie Avanzate-Franco Salvatore S.C.A.R.L., 80131 Naples, Italy., Nardelli C; Department of Molecular Medicine and Medical Biotechnologies, University of Naples Federico II, 80131 Naples, Italy.; CEINGE Biotecnologie Avanzate-Franco Salvatore S.C.A.R.L., 80131 Naples, Italy., Imbimbo C; Department of Neurosciences, Reproductive Sciences and Odontostomatology, University of Naples Federico II, 80130 Naples, Italy., Pastore L; Department of Molecular Medicine and Medical Biotechnologies, University of Naples Federico II, 80131 Naples, Italy.; CEINGE Biotecnologie Avanzate-Franco Salvatore S.C.A.R.L., 80131 Naples, Italy., Castaldo G; Department of Molecular Medicine and Medical Biotechnologies, University of Naples Federico II, 80131 Naples, Italy.; CEINGE Biotecnologie Avanzate-Franco Salvatore S.C.A.R.L., 80131 Naples, Italy.

Publikováno v: Microorganisms [Microorganisms] 2024 Oct 10; Vol. 12 (10). Date of Electronic Publication: 2024 Oct 10.

Decreased free D-aspartate levels in the blood serum of patients with schizophrenia.

Autor: Garofalo M; CEINGE Biotecnologie Avanzate 'Franco Salvatore', Naples, Italy.; Department of Environmental, Biological and Pharmaceutical Sciences and Technologies, Università degli Studi della Campania 'Luigi Vanvitelli', Caserta, Italy., De Simone G; Section of Psychiatry, Laboratory of Translational and Molecular Psychiatry and Unit of Treatment-Resistant Psychosis, Department of Neuroscience, Reproductive Sciences and Odontostomatology, University Medical School of Naples 'Federico II', Naples, Italy., Motta Z; 'The Protein Factory 2.0', Dipartimento di Biotecnologie e Scienze della Vita, Università degli Studi dell'Insubria, Varese, Italy., Nuzzo T; CEINGE Biotecnologie Avanzate 'Franco Salvatore', Naples, Italy.; Department of Environmental, Biological and Pharmaceutical Sciences and Technologies, Università degli Studi della Campania 'Luigi Vanvitelli', Caserta, Italy., De Grandis E; Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal, and Child Health - DINOGMI, University of Genoa, Genoa, Italy., Bruno C; Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal, and Child Health - DINOGMI, University of Genoa, Genoa, Italy.; Center of Translational and Experimental Myology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Giannina Gaslini, Genoa, Italy., Boeri S; Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal, and Child Health - DINOGMI, University of Genoa, Genoa, Italy., Riccio MP; Department of Maternal and Child Health, Unità Operativa semplice di Dipartimento (UOSD) of Child and Adolescent Psychiatry, Azienda Ospedaliera Universitaria (AOU) Federico II, Naples, Italy., Pastore L; CEINGE Biotecnologie Avanzate 'Franco Salvatore', Naples, Italy.; Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Università degli Studi di Napoli 'Federico II', Naples, Italy., Bravaccio C; Department of Medical and Translational Sciences, Child Neuropsychiatry, Federico II University, Napoli, Italy., Iasevoli F; Section of Psychiatry, Laboratory of Translational and Molecular Psychiatry and Unit of Treatment-Resistant Psychosis, Department of Neuroscience, Reproductive Sciences and Odontostomatology, University Medical School of Naples 'Federico II', Naples, Italy., Salvatore F; CEINGE Biotecnologie Avanzate 'Franco Salvatore', Naples, Italy.; Centro Interuniversitario per Malattie Multigeniche e Multifattoriali e loro Modelli Animali (Federico II, Naples; Tor Vergata, Rome and 'G. D'Annunzio', Chieti-Pescara), Naples, Italy., Pollegioni L; 'The Protein Factory 2.0', Dipartimento di Biotecnologie e Scienze della Vita, Università degli Studi dell'Insubria, Varese, Italy., Errico F; CEINGE Biotecnologie Avanzate 'Franco Salvatore', Naples, Italy.; Dipartimento di Agraria, Università degli Studi di Napoli 'Federico II', Portici, Italy., de Bartolomeis A; Section of Psychiatry, Laboratory of Translational and Molecular Psychiatry and Unit of Treatment-Resistant Psychosis, Department of Neuroscience, Reproductive Sciences and Odontostomatology, University Medical School of Naples 'Federico II', Naples, Italy., Usiello A; CEINGE Biotecnologie Avanzate 'Franco Salvatore', Naples, Italy.; Department of Environmental, Biological and Pharmaceutical Sciences and Technologies, Università degli Studi della Campania 'Luigi Vanvitelli', Caserta, Italy.

Publikováno v: Frontiers in psychiatry [Front Psychiatry] 2024 Jul 10; Vol. 15, pp. 1408175. Date of Electronic Publication: 2024 Jul 10 (Print Publication: 2024).

Energy Communities: The Concept of Waste to Energy-CHP Based District Heating System for an Italian Residential District

Autor: Pompei, L., Nardecchia, F., Lanza, V., Pastore, L. M., de Santoli, L.

Publikováno v: Sustainability in Energy and Buildings 2022 ISBN: 9789811987687

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8ce5c69bd41db3128bb4957ff3a0551a
https://doi.org/10.1007/978-981-19-8769-4_37

PeptiVAX: A new adaptable peptides-delivery platform for development of CTL-based, SARS-CoV-2 vaccines.

Autor: Feola S; Drug Research Program (DRP) ImmunoViroTherapy Lab (IVT), Division of Pharmaceutical Biosciences, Faculty of Pharmacy, Viikinkaari 5E, University of Helsinki, 00790 Helsinki, Finland; Helsinki Institute of Life Science (HiLIFE), Fabianinkatu 33, University of Helsinki, 00710 Helsinki, Finland; Translational Immunology Program (TRIMM), Faculty of Medicine Helsinki University, postal code Haartmaninkatu 8, University of Helsinki, 00290 Helsinki, Finland; Digital Precision Cancer Medicine Flagship (iCAN), University of Helsinki, FI-00014 Helsinki, Finland., Chiaro J; Drug Research Program (DRP) ImmunoViroTherapy Lab (IVT), Division of Pharmaceutical Biosciences, Faculty of Pharmacy, Viikinkaari 5E, University of Helsinki, 00790 Helsinki, Finland; Helsinki Institute of Life Science (HiLIFE), Fabianinkatu 33, University of Helsinki, 00710 Helsinki, Finland; Translational Immunology Program (TRIMM), Faculty of Medicine Helsinki University, postal code Haartmaninkatu 8, University of Helsinki, 00290 Helsinki, Finland; Digital Precision Cancer Medicine Flagship (iCAN), University of Helsinki, FI-00014 Helsinki, Finland., Fusciello M; Drug Research Program (DRP) ImmunoViroTherapy Lab (IVT), Division of Pharmaceutical Biosciences, Faculty of Pharmacy, Viikinkaari 5E, University of Helsinki, 00790 Helsinki, Finland; Helsinki Institute of Life Science (HiLIFE), Fabianinkatu 33, University of Helsinki, 00710 Helsinki, Finland; Translational Immunology Program (TRIMM), Faculty of Medicine Helsinki University, postal code Haartmaninkatu 8, University of Helsinki, 00290 Helsinki, Finland; Digital Precision Cancer Medicine Flagship (iCAN), University of Helsinki, FI-00014 Helsinki, Finland., Russo S; Drug Research Program (DRP) ImmunoViroTherapy Lab (IVT), Division of Pharmaceutical Biosciences, Faculty of Pharmacy, Viikinkaari 5E, University of Helsinki, 00790 Helsinki, Finland; Helsinki Institute of Life Science (HiLIFE), Fabianinkatu 33, University of Helsinki, 00710 Helsinki, Finland; Translational Immunology Program (TRIMM), Faculty of Medicine Helsinki University, postal code Haartmaninkatu 8, University of Helsinki, 00290 Helsinki, Finland; Digital Precision Cancer Medicine Flagship (iCAN), University of Helsinki, FI-00014 Helsinki, Finland., Kleino I; Turku Bioscience Centre, University of Turku and Åbo Akademi University Turku, Turku, Finland., Ylösmäki L; Valo Therapeutics Oy, Helsinki, Finland., Kekäläinen E; Translational Immunology Program (TRIMM), Faculty of Medicine Helsinki University, postal code Haartmaninkatu 8, University of Helsinki, 00290 Helsinki, Finland; HUSLAB Clinical Microbiology, HUS Diagnostic Center, University of Helsinki and Helsinki University Hospital, Helsinki, Finland., Hästbacka J; HUSLAB Clinical Microbiology, HUS Diagnostic Center, University of Helsinki and Helsinki University Hospital, Helsinki, Finland., Pekkarinen PT; Translational Immunology Program (TRIMM), Faculty of Medicine Helsinki University, postal code Haartmaninkatu 8, University of Helsinki, 00290 Helsinki, Finland; Division of Intensive Care Medicine, Department of Anaesthesiology and Intensive Care, University of Helsinki and Helsinki University Hospital, Finland., Ylösmäki E; Drug Research Program (DRP) ImmunoViroTherapy Lab (IVT), Division of Pharmaceutical Biosciences, Faculty of Pharmacy, Viikinkaari 5E, University of Helsinki, 00790 Helsinki, Finland; Helsinki Institute of Life Science (HiLIFE), Fabianinkatu 33, University of Helsinki, 00710 Helsinki, Finland; Translational Immunology Program (TRIMM), Faculty of Medicine Helsinki University, postal code Haartmaninkatu 8, University of Helsinki, 00290 Helsinki, Finland; Digital Precision Cancer Medicine Flagship (iCAN), University of Helsinki, FI-00014 Helsinki, Finland., Capone S; ReiThera Srl, Rome, Italy., Folgori A; ReiThera Srl, Rome, Italy., Raggioli A; ReiThera Srl, Rome, Italy., Boni C; Laboratory of Viral Immunopathology, Unit of Infectious Disease and Hepatology, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy., Tiezzi C; Department of Medicine and Surgery, University of Parma, Parma, Italy., Vecchi A; Laboratory of Viral Immunopathology, Unit of Infectious Disease and Hepatology, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy., Gelzo M; CEINGE-Biotecnologie Avanzate, Naples, Italy; Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Università di Napoli Federico II, Naples, Italy., Kared H; ImmunoScape Pte Ltd, Singapore., Nardin A; ImmunoScape Pte Ltd, Singapore., Fehlings M; ImmunoScape Pte Ltd, Singapore., Barban V; Valo Therapeutics Oy, Helsinki, Finland., Ahokas P; Valo Therapeutics Oy, Helsinki, Finland., Viitala T; Pharmaceutical Biophysics Research Group, Drug Research Program, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland., Castaldo G; CEINGE-Biotecnologie Avanzate, Naples, Italy; Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Università di Napoli Federico II, Naples, Italy., Pastore L; CEINGE-Biotecnologie Avanzate, Naples, Italy; Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Università di Napoli Federico II, Naples, Italy; Department of Molecular Medicine and Medical Biotechnology, Naples University 'Federico II', S. Pansini 5, Italy., Porter P; Valo Therapeutics Oy, Helsinki, Finland; School of Nursing, Curtin University, GPO Box U 1987, Perth, WA 6845, Australia., Pesonen S; Valo Therapeutics Oy, Helsinki, Finland., Cerullo V; Drug Research Program (DRP) ImmunoViroTherapy Lab (IVT), Division of Pharmaceutical Biosciences, Faculty of Pharmacy, Viikinkaari 5E, University of Helsinki, 00790 Helsinki, Finland; Helsinki Institute of Life Science (HiLIFE), Fabianinkatu 33, University of Helsinki, 00710 Helsinki, Finland; Translational Immunology Program (TRIMM), Faculty of Medicine Helsinki University, postal code Haartmaninkatu 8, University of Helsinki, 00290 Helsinki, Finland; Digital Precision Cancer Medicine Flagship (iCAN), University of Helsinki, FI-00014 Helsinki, Finland; Institute for Molecular Medicine Finland, FIMM, Helsinki Institute of Life Science (HiLIFE), University of Helsinki, FI-00014 Helsinki, Finland; Department of Molecular Medicine and Medical Biotechnology, Naples University 'Federico II', S. Pansini 5, Italy. Electronic address: vincenzo.cerullo@helsinki.fi.

Publikováno v: International journal of biological macromolecules [Int J Biol Macromol] 2024 Mar; Vol. 262 (Pt 1), pp. 129926. Date of Electronic Publication: 2024 Feb 06.